Evidence map›Paper›PMID 42294638›Full record

ArticleJournal of virology2026

NFX1-123 is required for keratinocyte differentiation and HPV 16 DNA maintenance in early and persistent infection models.

Maura A Dankoski, DeShawn Thompson, Kevin M Quist, Rachel A Katzenellenbogen

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maura A DankoskiTranslational Cancer Biology Program, IU Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0002-8093-430X
DeShawn ThompsonDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kevin M QuistDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Rachel A KatzenellenbogenTranslational Cancer Biology Program, IU Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0002-2597-2071

Funding

Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancerR01CA172742 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI KATZENELLENBOGEN, RACHEL ADRIA · 2014 to 2024
$4.1M
National Institute of Allergy and Infectious Diseases T32AI060519NCI NIH HHS R01 CA172742NCI NIH HHS R01CA172742NIAID NIH HHS T32 AI060519
6 · The paper itself

Abstract

Persistent high-risk human papillomavirus (HR HPV) infections cause nearly 5% of cancers worldwide, including cervical and oropharyngeal cancers. HR HPVs sustain long-term infections in stratified epithelial tissues by maintaining copies of viral genomes in basal keratinocytes and utilizing the cellular differentiation processes in the upper layers to coordinate key steps in the viral life cycle. We have demonstrated previously that the endogenous host protein NFX1-123 bound directly to the HR HPV type 16 oncoprotein E6 (16E6), and that this partnership increased keratinocyte proliferation and differentiation, two processes that are both required for persistent HPV 16 infections. As there is a range of endogenous expression of NFX1-123 in normal basal keratinocytes, we aimed to investigate the role of NFX1-123 abundance on the initiation and persistence of HPV 16 infections. In this study, we utilized keratinocytes with overexpressed, endogenous, or reduced levels of NFX1-123 and infected these cells with an HPV 16 quasivirus (Qsv) to interrogate changes to keratinocyte growth and viral DNA copy numbers with NFX1-123 modulation. Keratinocytes with reduced NFX1-123 had blunted differentiation and stratification in raft cultures, and this correlated with decreased HPV 16 Qsv DNA copies. Similarly, when we reduced NFX1-123 in W12E cells, a cervical cell line harboring episomal HPV 16 genomes, we saw a decrease in raft culture differentiation and thickness, and fewer viral genome copies compared to W12E cells with endogenous NFX1-123. These findings indicate the importance of NFX1-123 on the initiation and maintenance of HPV 16 infections that may persist and progress to cancer.IMPORTANCEA high-risk human papillomavirus (HPV) infection that persists for decades is the biggest risk factor for the development of cervical and other HPV-associated cancers. The ability of HPV to maintain its genome and persist in stratified epithelium is dependent on its partnership with host proteins and its co-opting of cellular pathways. Here, we investigate how the abundance of HPV 16's host protein partner NFX1-123 affects viral genome maintenance and replication in monolayer and three-dimensional cultures, modeling both early and persistent infection. This study reveals that NFX1-123 is required for keratinocyte differentiation and stratification in raft cultures, and the disruption of these processes significantly impedes the ability of HPV 16 to maintain its episomal genome at consistent copy numbers. These findings indicate the importance of NFX1-123 for the persistence of HPV 16 infections and encourage further investigation of NFX1-123 as a potential therapeutic target in HPV 16-positive cancers and precancers.

Indexed as

Cell DifferentiationDNA, ViralHuman papillomavirus 16KeratinocytesPapillomavirus InfectionsPersistent InfectionGenome, ViralHumansOncogene Proteins, ViralRepressor ProteinsDNA, ViralNFX1 protein, humanOncogene Proteins, ViralRepressor ProteinsdifferentiationHPVinfectionNFX1-123

Identifiers

PMID42294638
PMCPMC13386821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.